Abiopharma

FDA approve DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

FDA approve SPIRONOLACTONE

FDA approve ETHINYL ESTRADIOL; LEVONORGESTREL

RCKT INVESTOR NOTICE: Robbins Geller Rudman & Dowd Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Result of Annual General Meeting

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Ceasing to be a substantial holder

New Form 4 - CareCloud, Inc. Filed: 2025-06-18 AccNo: 0001641172-25-015661 Size: 5 KB

New Form 4 - ARDELYX, INC. Filed: 2025-06-18 AccNo: 0001628280-25-032226 Size: 5 KB

New Form 4 - Axsome Therapeutics, Inc. Filed: 2025-06-18 AccNo: 0000950170-25-088105 Size: 18 KB